Fundraising Fox
Bluebird Ventures
Venture capitalPalo Alto · Seed–Series B · 1 people tracked
Also known as BLUEBIRD VENTURES GP I, LLC
Find your way into Bluebird Ventures
4,165 people in our graph share verified history with the Bluebird Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Bluebird Ventures backs early-stage life sciences companies, drawing on the founder's deep operating and investing experience in biotech, diagnostics, and therapeutics. The firm's activity centers on areas such as genomics, oncology, cancer detection, and novel therapies, reflecting its founder's track record investing in and building companies later acquired by major industry players.
Source: firm website, verified Sep 29, 2026.
What founders say
No founder feedback on Bluebird Ventures yet.
Team · 1 people
from public directories
What they invest in
from 10 of 14 portfolio companiesBiotech ×9Healthtech ×7Medical Devices ×5Digital Health ×2AI & Machine Learning ×1Deep Tech ×1Fintech ×1SaaS ×1
HQs:United States×8United Kingdom×1Netherlands×1
Investments · 14 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 22021 · 12020 · 12019 · 12014 · 17 dated
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMenlo Park, US
Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)inAaron Freidin(Executive Officer)inJosh Ofman(Executive Officer)inRobert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)in
PartnerJeffrey Bird· solo GP
Co-investorsAmino CapitalARCH Venture PartnersBezos ExpeditionsDecheng CapitalDentsu VenturesFelicis Ventures+13 more
-2.png)
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Casdin CapitalEuropean Innovation Council FundEuropean Investment Bank+6 more
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Co-founder and first Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Pam Taub, M.D., FACC(Co-founder)
PartnerJeffrey Bird· solo GP
Co-investorsBroadview VenturesLongitude CapitalAdams Street PartnersARCH Venture PartnersVertex VenturesVertex Ventures HC
Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries.
BiotechHealthtechMedical DevicesPalo Alto, US
Ravindra Majeti(Director)Irving Weissman(Director)Eric Jensen(Executive Officer)
BoardChristopher Schaepe(Director)inJeffrey Bird(Director)Dennis Henner(Director)
PartnerJeffrey Bird· solo GP
Co-investorsGV (Google Ventures)Lightspeed Venture PartnersSofinnova VenturesClarus VenturesSutter Hill VenturesWellington Management
Kriya provides working capital loans and business finance products to UK and European businesses, helping them manage cash flow, fund wholesale orders, and scale their buyer base.
FintechSaaS
Anil Stocker(Founder)in
Co-investorsMouro CapitalNorthzoneForesite CapitalJDRF T1D FundNarya CapitalPatient Square Capital+2 more
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.
BiotechHealthtechMorrisville, US
Shankar Ramaswamy(Co-Founder, Chairman & CEO)inRoger Jeffs(Co-Founder & Vice Chairman)inFraser Wright(Scientific Co-Founder & Chief Gene Therapy Officer)inShankar Ramaswamy, M.D.(Founder)inMichele Stone(Chief Scientific Officer)inKatherine Eade(Chief Legal Officer)
PartnerJeffrey Bird· solo GP
Co-investorsPatient Square CapitalPremji InvestAmplo VenturesForesite CapitalHolland CapitalJDRF T1D Fund+2 more
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology.
BiotechHealthtechSan Diego, US
William J. Dower(Co-founder and Scientific Advisor)Michael C. Needels(Co-founder and CTO)Ronald W. Barrett(CEO and Chairman of the Board)Joseph Leveque(CEO, President, and Board Member)in
PartnerJeffrey Bird· solo GP
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
PartnerJeffrey Bird· solo GP
Co-investors+ND CapitalARCH Venture PartnersCraft VenturesFounders FundParadigmSam Altman+1 more
Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.
BiotechDigital HealthHealthtechMedical Devices
PartnerJeffrey Bird· solo GP
Co-investorsFrazier Life SciencesLightstone VenturesProspect Venture PartnersKhosla VenturesNFDG
Procyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.
BiotechHealthtechMedical DevicesHouston, US
Reynolds, III M. Delagado(Director)Benjamin A. Hertzog(Executive Officer, Director)Dr. Fain(Founder/Executive)Jason J Heuring(Executive Officer)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
PartnerJeffrey Bird· solo GP
Co-investorsScientific Health DevelopmentTexas VenturesFannin Goldenrod Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cardero TherapeuticsHelixTeneobioVerinata Health
Exits · 4
1 IPOs · 3 acquisitions · showing 3GrailNASDAQ: GRALForty Seven Incacq. by GileadPortola Pharmaceuticalsacq. by Alexion
Portfolio news
latest coverage across their companiesLeyden Labs · techfundingnews.com · Jun 25, 2026
Frequently asked questions
- How many investments has Bluebird Ventures made?
- Bluebird Ventures has 14 tracked investments, 4 of which have exited.
- What stage does Bluebird Ventures invest at?
- Bluebird Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Bluebird Ventures focus on?
- Bluebird Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Bluebird Ventures located?
- Bluebird Ventures is headquartered in Palo Alto, US.
- Who does Bluebird Ventures co-invest with?
- Bluebird Ventures most often shares deals with ARCH Venture Partners, Foresite Capital, GV (Google Ventures), among 31 tracked co-investors.
Co-investors · 6
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.
Maverick Capital is an investment management firm operating a unified platform of hedged and long strategies, serving both public and private investors since launching its first long/short equity fund in 1993.
Firms observed investing alongside Bluebird Ventures, from public investor directories. Shared companies are the overlap with Bluebird Ventures's recorded portfolio.
Similar investors
Investinor AS is a Norwegian investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
Third Rock Ventures is a venture capital firm that discovers, launches, and builds life sciences and biotechnology companies developing novel medicines and therapies.
Life Sciences Greenhouse Investments (LSGI) is an evergreen venture fund that provides early-stage capital and operational support to Pennsylvania life science companies working on drug discovery, diagnostics, devices, and healthcare IT solutions.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.